IOPtima – Signing on a Non-Binding Memorandum of Understanding for a Full Purchase

BioLight is pleased to announce that IOptima Ltd., a subsidiary of the Company, has signed on April 19, 2017, a non-binding memorandum of understanding for a full purchase in the stages of IOPtima by a Chinese pharmaceutical company.

Link to complete article

Link to Newsroom

Comments are closed.